Table 1 Bivariate Analyses between IV Vitamin C Group and Comparison Group
|  | All Patients (n = 1390) |  | |
|---|---|---|---|
Demographic Characteristic | IV vitamin C (n = 212) | Comparison (n = 1178) | p |
Continuous | μ ± SE | μ ± SE |  |
Age (years) | 62 ± 1.15 | 59 ± 0.51 | 0.02 |
Length of Stay (hours) | 302 ± 18 | 319 ± 13 | 0.44 |
Length of Stay in ICU (hours) | 119 ± 10 | 76 ± 6 | < 0.001 |
Categorical | n (%) | n (%) | p |
Insurance Status | |||
  Government | 182 (86) | 893 (76) | 0.001 |
  Other | 30 (14) | 285 (24) |  |
Race | |||
  Black | 118 (56) | 611 (52) | 0.57 |
  White | 84 (39) | 500 (42) |  |
  Other/Unknown | 10 (5) | 67 (6) |  |
Biological Sex | |||
  Female | 100 (47) | 542 (46) | 0.76 |
  Male | 112 (53) | 636 (54) | |
Hypertension | |||
  Yes | 71 (33) | 454 (39) | 0.16 |
  No | 141 (67) | 724 (61) |  |
Diabetes | |||
  Yes | 17 (8) | 112 (10) | 0.49 |
  No | 195 (92) | 1066 (90) |  |
Vasoactive Drug Use* | |||
  Yes | 36 (17) | 193 (16) | 0.83 |
  No | 176 (83) | 985 (84) |  |
AKI | |||
  Yes | 145 (68) | 550 (47) | < 0.001 |
 No | 67 (32) | 628 (53) |  |
Death | |||
  Yes | 30 (14) | 89 (8) | 0.002 |
  No | 182 (86) | 1089 (92) |  |